Quest Diagnostics Incorporated (LON:0KSX)

Market Cap	16.88B +19.7%
Revenue (ttm)	8.20B +11.8%
Net Income	734.08M +13.9%
EPS	6.50 +13.8%
Shares Out	n/a
PE Ratio	22.99
Forward PE	19.21
Dividend	2.40 (1.16%)
Ex-Dividend Date	Jan 13, 2026

Volume	11
Average Volume	564
Open	212.00
Previous Close	208.00
Day's Range	209.10 - 212.72
52-Week Range	157.73 - 213.09
Beta	0.68
RSI	75.58
Earnings Date	Feb 10, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1967
• Employees: 57,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KSX

Financial Performance

In 2025, Quest Diagnostics's revenue was $11.04 billion, an increase of 11.78% compared to the previous year's $9.87 billion. Earnings were $988.00 million, an increase of 14.09%.

Financial numbers in USD